ITMI960501A0 - - Google Patents

Info

Publication number
ITMI960501A0
ITMI960501A0 ITMI960501A ITMI960501A ITMI960501A0 IT MI960501 A0 ITMI960501 A0 IT MI960501A0 IT MI960501 A ITMI960501 A IT MI960501A IT MI960501 A ITMI960501 A IT MI960501A IT MI960501 A0 ITMI960501 A0 IT MI960501A0
Authority
IT
Italy
Application number
ITMI960501A
Other languages
Italian (it)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to IT96MI000501A priority Critical patent/IT1283252B1/it
Publication of ITMI960501A0 publication Critical patent/ITMI960501A0/it
Priority to EP97830103A priority patent/EP0795329B1/en
Priority to ES97830103T priority patent/ES2154018T3/es
Priority to DE69703994T priority patent/DE69703994T2/de
Publication of ITMI960501A1 publication Critical patent/ITMI960501A1/it
Application granted granted Critical
Publication of IT1283252B1 publication Critical patent/IT1283252B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IT96MI000501A 1996-03-15 1996-03-15 Soluzioni di piroxicam iniettabili per via parenterale IT1283252B1 (it)

Priority Applications (4)

Application Number Priority Date Filing Date Title
IT96MI000501A IT1283252B1 (it) 1996-03-15 1996-03-15 Soluzioni di piroxicam iniettabili per via parenterale
EP97830103A EP0795329B1 (en) 1996-03-15 1997-03-07 Parenterally injectable piroxicam solutions
ES97830103T ES2154018T3 (es) 1996-03-15 1997-03-07 Soluciones inyectables por via parenteral que contienen piroxicam.
DE69703994T DE69703994T2 (de) 1996-03-15 1997-03-07 Parenteral injizierbare Lösungen enthaltend Piroxicam

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96MI000501A IT1283252B1 (it) 1996-03-15 1996-03-15 Soluzioni di piroxicam iniettabili per via parenterale

Publications (3)

Publication Number Publication Date
ITMI960501A0 true ITMI960501A0 (enExample) 1996-03-15
ITMI960501A1 ITMI960501A1 (it) 1997-09-15
IT1283252B1 IT1283252B1 (it) 1998-04-16

Family

ID=11373628

Family Applications (1)

Application Number Title Priority Date Filing Date
IT96MI000501A IT1283252B1 (it) 1996-03-15 1996-03-15 Soluzioni di piroxicam iniettabili per via parenterale

Country Status (4)

Country Link
EP (1) EP0795329B1 (enExample)
DE (1) DE69703994T2 (enExample)
ES (1) ES2154018T3 (enExample)
IT (1) IT1283252B1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
AU2003100262B4 (en) * 2003-04-07 2003-09-18 Jurox Pty Ltd Stable carprofen composition
BRPI0611170A2 (pt) * 2005-05-27 2010-08-17 Panacea Biotec Ltd composições injetáveis e processo para o preparo de tais composições
KR101383941B1 (ko) 2012-03-09 2014-04-10 동아에스티 주식회사 피록시캄 또는 약제학적으로 허용되는 그의 염과 히알루론산 또는 약제학적으로 허용되는 그의 염의 안정한 액상 조성물 및 그 제조방법
JP6723162B2 (ja) 2014-04-21 2020-07-15 ヘロン セラピューティクス， インコーポレイテッドＨｅｒｏｎ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． ポリオルトエステルおよび有機酸添加剤の組成物
US9801945B2 (en) 2014-04-21 2017-10-31 Heron Therapeutics, Inc. Long-acting polymeric delivery systems
CN106535886A (zh) * 2014-04-21 2017-03-22 赫伦治疗有限公司 长效聚合物输送系统
EP3509601A1 (en) 2014-04-21 2019-07-17 Heron Therapeutics, Inc. A pharmaceutical composition comprising a delivery system, an amide-type local anesthetic, and meloxicam
WO2021146215A1 (en) 2020-01-13 2021-07-22 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods
CA3203561A1 (en) 2021-01-12 2022-07-21 Adrian Neil Verity Sustained release drug delivery systems and related methods

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4434163A (en) * 1981-06-01 1984-02-28 Pfizer Inc. Water-soluble benzothiazine dioxide salts
US4434164A (en) * 1981-06-01 1984-02-28 Pfizer Inc. Crystalline benzothiazine dioxide salts
DE3217315C2 (de) * 1982-05-08 1986-05-22 Gödecke AG, 1000 Berlin Arzneimittelzubereitungen mit einem Gehalt an Oxicam-Derivaten
DE3437232A1 (de) * 1984-10-10 1986-04-17 Mack Chem Pharm Stabilisierte injektionsloesungen von piroxicam
IT1207994B (it) * 1986-01-03 1989-06-01 Therapicon Srl Sali idrosulubili di composti adattivita' antiinfiammatoria ed analgesica, loro preparazione ed utilizzo in composizioni farmaceutiche.
IT1216686B (it) * 1988-04-01 1990-03-08 Chiesi Farma Spa Formulazioni farmaceutiche acquose di piroxicam e procedimento per laloro preparazione.
JPH0418022A (ja) * 1990-05-10 1992-01-22 Fujikawa Kk ピロキシカムの安定水溶液ならびにその製造法
KR930010398B1 (ko) * 1990-09-05 1993-10-23 배명진 음성신호 파형에서 비대칭율을 이용한 전이구간 검출방법
US5420124A (en) * 1994-01-12 1995-05-30 Kim; Young S. Stable, painless piroxicam potassium injectable composition

Also Published As

Publication number Publication date
EP0795329A1 (en) 1997-09-17
ITMI960501A1 (it) 1997-09-15
DE69703994D1 (de) 2001-03-08
ES2154018T3 (es) 2001-03-16
EP0795329B1 (en) 2001-01-31
IT1283252B1 (it) 1998-04-16
DE69703994T2 (de) 2001-05-23

Similar Documents

Publication Publication Date Title
IN192450B (enExample)
AR026661A2 (enExample)
BRPI9713914B8 (enExample)
IN191881B (enExample)
IN191437B (enExample)
IN186126B (enExample)
IN190529B (enExample)
ITGE960014A0 (enExample)
ITMI960114A0 (enExample)
BR7600721U (enExample)
ITGE960057A0 (enExample)
BR7601346U (enExample)
BR9603859A (enExample)
ITMI960494V0 (enExample)
CN3042589S (enExample)
CN3042853S (enExample)
CN3039696S (enExample)
CN3043073S (enExample)
CN3043415S (enExample)
CN3039811S (enExample)
CN3040024S (enExample)
CN3041383S (enExample)
CN3039344S (enExample)
CN3043413S (enExample)
CN3040621S (enExample)

Legal Events

Date Code Title Description
0001 Granted